Bal Pharma Limited (BALPHARMA) — Capital Reinvestment Ratio
Bal Pharma Limited (BALPHARMA) has a Capital Reinvestment Ratio of 1.07x as of September 2025, meaning it reinvests 1% of its operating cash flow (Rs101.16 Million) in capital expenditures (Rs107.94 Million). See net asset quality index of Bal Pharma Limited to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Bal Pharma Limited Capital Reinvestment Ratio (2007–2025)
This chart tracks Bal Pharma Limited's Capital Reinvestment Ratio across 15 annual periods. Check BALPHARMA capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Bal Pharma Limited (2007–2025)
Year-by-year Capital Reinvestment Ratio for Bal Pharma Limited from 2007 to 2025. For live market cap and broader valuation context, see BALPHARMA market cap overview.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 4.44x | Rs42.32 Million | Rs187.87 Million | ▲ +822.0% |
| 2024 | 0.48x | Rs228.06 Million | Rs109.80 Million | ▲ +57.5% |
| 2022 | 0.31x | Rs277.08 Million | Rs84.69 Million | ▲ +95.0% |
| 2021 | 0.16x | Rs217.81 Million | Rs34.13 Million | ▼ -28.5% |
| 2020 | 0.22x | Rs231.01 Million | Rs50.63 Million | ▼ -80.2% |
| 2019 | 1.11x | Rs77.58 Million | Rs85.94 Million | ▼ -22.6% |
| 2017 | 1.43x | Rs58.58 Million | Rs83.82 Million | ▲ +270.0% |
| 2015 | 0.39x | Rs145.33 Million | Rs56.20 Million | ▼ -31.0% |
| 2014 | 0.56x | Rs133.13 Million | Rs74.61 Million | ▲ +114.5% |
| 2013 | 0.26x | Rs163.39 Million | Rs42.69 Million | ▼ -7.5% |
| 2012 | 0.28x | Rs128.58 Million | Rs36.34 Million | ▼ -11.2% |
| 2011 | 0.32x | Rs46.09 Million | Rs14.66 Million | ▼ -64.6% |
| 2009 | 0.90x | Rs127.64 Million | Rs114.64 Million | ▼ -43.2% |
| 2008 | 1.58x | Rs90.75 Million | Rs143.54 Million | ▼ -22.0% |
| 2007 | 2.03x | Rs51.55 Million | Rs104.51 Million | — |